Ypsomed and i-SENS global partnership signing ceremony
Simon Michel , CEO Ypsomed and Geun Sig Cha, CEO i-SENS

Press Releases Ypsomed Group

Burgdorf – By entering into new partnerships and cooperations, Ypsomed has expanded its diabetes therapy offerings. With the goal of freedom of choice for the users of the mylife YpsoPump, the first study on the insulin pump with open interfaces as well as the connection to the therapy management solution diasend® by Glooko starts. In addition, Ypsomed launches the new blood glucose monitoring system mylife Aveo in spring 2020.

YpsoPump – The intuitive insulin pump system
YpsoPump – The intuitive insulin pump system

Press Releases Ypsomed Canada

Burgdorf – Ypsomed Canada, a subsidiary of Ypsomed A.G has received Health Canada approval for the YpsoPump insulin pump. The market entry in Canada is another important milestone in the consistently pursued global growth strategy of the parent company.